Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Christian Hospital Northeast Northwest
Study ID
NCT07499882
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chemotherapy Induced Peripheral Neuropathy (CIPN)

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Ziconotide — DRUG
    Real world evidence trial. Patients that are on intrathecal ziconotide will be observed for two years, to determine whether or not this drug is effective for chemotherapy induced peripheral neuropathy.

Study Details

The purpose of this observational, data collection, research is to evaluate if ziconotide, a commercially approved medication given by a FDA cleared intrathecal pump, for chronic pain is effective in the treatment of chemotherapy-induced peripheral neuropathy (CIPN) a common and often long-lasting side effect of cancer treatment.

Key Dates

Start date
May 2, 2026
Status verified
Mar 2026
Primary completion
May 1, 2028
Completion
May 1, 2028

Study Design

Enrollment
24 participants (estimated)

Arms

  • Arm: Study group
    This is the only group. All subjects will receive ziconotide via the Medtronic Synchromed intrathecal pump.

Primary Outcome Measure

Assess whether or not patients' pain score from VAS changes when receiving intrathecal ziconotide [ Time Frame: From enrollment to the end of treatment at 24 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Christian HospitalSt LouisMissouri63136
Maksim Shoykhet, BSN
[email protected]
314-653-5228
Cassandra Wania, BSN
[email protected]
314-653-5228
Christopher L Beuer, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in St Louis, MO

By research site
Christian Hospital· St Louis, MO

Related Studies